Agentic AI is emerging as the next phase of evolution beyond Generative AI, acting as a coordinated, goal-oriented “digital scientist” capable of planning, executing, and learning across complex R&D workflows. For organizations navigating increasing drug development costs and intensifying regulatory scrutiny, moving beyond chatbots and copilots to a fully agentic framework can compress protocol design and study start-up timelines by 30–50%, unlock scientific capacity, and improve decision quality by combining proprietary data with the latest external literature. However, in a regulated industry, “black box” autonomy is a liability.
Discover how LabVantage CORTEX delivers governed agentic execution, integrated directly into the System of Record, with provenance-first traceability and Human-in-the-Loop escalation gates that ensure every agentic action meets GxP, 21 CFR Part 11, and ALCOA+ requirements.
